Search

Search Constraints

You searched for: Author/Creator Tajiri, Kazuto

Search Results

11. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort. Issue 10 (October 2021)

12. Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis. (21st December 2018)

13. Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting. Issue 7 (29th November 2020)

14. Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib. (3rd June 2022)

15. Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis. Issue 3 (2nd December 2021)

16. Endoscopic ultrasound‐guided fine‐needle biopsy for the diagnosis of gastric linitis plastica. Issue 1 (2nd September 2021)

17. Glasgow prognostic score predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib: a multicenter analysis. Issue 8 (29th June 2022)

18. Impact of albumin–bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time‐dependent receiver operating characteristic. Issue 6 (27th February 2019)

19. Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5‐fluorouracil. Issue 7 (9th October 2014)

20. Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5‐fluorouracil. Issue 7 (9th October 2014)